Faculty of Science
CODE
12062
SUBCODE
12062-MFT-MPT
ENTRY

Sept 2027 Entry

STUDY MODE
Mixed Mode
DURATION

1 year (Full-time)
2 years (Part-time)

CREDIT REQUIRED

31

FUND TYPE
Self-Financed

An option of two-year dual degree programme of PolyU's MSc in Biopharmaceutical Development and Commercialization (生物醫藥研發及產業化理學碩士) and Nanyang Technological University (NTU)'s MSc in Biomedical Data Science (生物醫學數據科學理學碩士) is available. Students should indicate their interest for this dual degree programme when submitting the application via eAdmission. For more details of this dual degree curriculum, please visit the page here.

Application Deadline
Local - Mixed Mode
Sept 2027 Entry
Early Round: 2026-10-20
Main Round: 2027-02-25
Non-local - Mixed Mode
Sept 2027 Entry
Early Round: 2026-10-20
Main Round: 2027-02-25

What's New

More News

QS1
  • Taught Postgraduate
  • Undergraduate
QS World University Rankings 2027
POLYU JUPAS ADMISSIONS Q&A
  • Undergraduate
Plan Ahead with PolyU: Join our JUPAS Admissions Q&A, 9 May on campus and 11 – 13 May online
About Programme
How to Apply
Aims & Characteristics

The biopharmaceutical industry is at the forefront of medical innovation, as it develops transformative therapies that address unmet medical needs. This industry is undergoing rapid evolution, and thus there is a high demand for professionals who are well versed in the complexities of biopharmaceutical development and commercialisation. This programme aims to bridge a current educational gap in biopharmaceutical education by providing a comprehensive curriculum that covers a combination of scientific, business, regulatory, and ethical aspects of the biopharmaceutical industrial landscape. 

 

Specifically, the programme aims to achieve the following: 

  • Provide students with a deep understanding of biopharmaceutical science through coursework and/or internships.

  • Educate students on the entire lifecycle of biopharmaceutical products, from R&D to commercialisation.

  • Develop students’ critical thinking skills to allow them to innovate within the biopharmaceutical sector.

  • Foster a holistic perspective by integrating science, regulation, business, and ethics.

  • Produce well-prepared graduates who are suited to diverse roles within the biopharmaceutical industry. 

 

Upon successful completion of the programme, students will have the following.

  • Scientific proficiency: Students will have a deep understanding of the science underpinning biopharmaceuticals and state-of-the-art therapies, such as protein engineering and cell and gene therapies.

  • Commercial insight: Students will be equipped with key insights into the business side of biopharmaceuticals, such as patenting, pricing, and market entry.

  • Regulatory knowledge: Students will have mastered the regulatory aspects of biopharmaceuticals, such as intellectual property strategy, clinical trials, drug approvals, and ethics.

  • Interdisciplinary collaboration skills: Students will have developed and refined their collaborative skills and learnt to work with teams from various disciplines on biopharmaceutical projects.

Recognition & Prospects

The Master of Science in Biopharmaceutical Development and Commercialisation programme will equip graduates with multidisciplinary skills that will allow them to pursue diverse roles across various levels within biotechnology and pharmaceutical companies. Graduates will be prepared to take on everything from entry-level positions, such as research associate and clinical trial coordinator, to mid-level roles involving project management, marketing, and regulatory affairs. For students seeking greater responsibility, the programme will also prepare them for senior specialist roles overseeing areas such as research and development, partnering, manufacturing, and quality assurance. As graduates gain experience, they can eventually qualify for higher-level management or executive positions within areas such as business development, operations, and product development. Beyond private industry, graduates may have opportunities to work for regulatory bodies, research institutions, or non-profit organisations focused on medical innovation. Equipped with science, business and regulatory expertise, graduates will be well-positioned to forge careers spanning the many functions and levels that drive progress in this vitally important and rapidly advancing sector.

Curriculum

Core Subjects (3 credits for each subject unless specified) 

ABCT5101 Modern Approaches in Biopharmaceutical Development 
ABCT5102 Pharmacology and Toxicology in Biotherapeutics 
ABCT5103 Intellectual Property Strategy for Biotech Entrepreneurship 
ABCT5104 Regulatory Science for Biotech Products 
ABCT5105 Ethics and Management in Life Sciences 
ABCT5106 Technology Platforms in Drug Discovery 
ABCT5107 Advanced Therapeutic Products 
 

Choose one subject in each pool 
Pool 1: ABCT5108 Investment Financing and Risk Management in Biobusiness OR 
             ABCT5109 Entrepreneurship- From Lab to Launch  
Pool 2: ABCT5110 Industrial Attachment (6 credits) OR 
             ABCT5113 Research Project (6 credits) 
 

Academic Integrity and Ethics (AIE) Requirement Subject (1 credit)

  • Academic Integrity and Ethics in Science

For the curriculum of the two-year dual degree programme of PolyU's MSc in Biopharmaceutical Development and Commercialization and NTU's MSc in Biomedical Data Science, please click here.

Credit Required for Graduation

31

Programme Leader(s)

Prof. Wong Tsun-ting, Clarence 
BSc, PhD

Subject Area
Biopharmaceutical Development and Commercialization
Entrance Requirements
  • A Bachelor’s degree or the equivalent in biological/life sciences, chemistry, biomedical sciences/engineering, health science, or a related discipline.

  • Preference will be given to applicants having at least 1 year of relevant work experience.

  • If the applicant is not a native speaker of English, and his/her Bachelor’s degree or equivalent qualification is awarded by institutions where the medium of instruction is not English, he/she is expected to fulfil the University’s minimum English language requirement for admission purpose. Please refer to the "Admission Requirements" section for details.

Enquiries

For further programme information, please contact us via email: msc.bdc@polyu.edu.hk

Tuition Fee

HK$8,400 per credit for local and non-local students. Tuition fee will not be charged for the 1-credit AIE subject.

 

Scholarships 

Two one-off entry scholarships of HK$10,000 each will be granted to applicants who are admitted during the Early Round Application period (by 20 October 2026) and obtained a Bachelor’s degree with Second Class (Division I) Honours or above (or equivalent). Another two one-off entry scholarships of HK$10,000 each will be granted to applicants with excellent academic achievements. The recipients are not allowed to concurrently hold more than one Entry Scholarship awarded by the Department. 

 

PolyU reserves the right to change or withdraw the scholarship at any time. In case of any dispute / disagreement, PolyU’s decision is final.

View Other Programmes